P3 Health Company Insiders
PIIIW Stock | USD 0.01 0 21.17% |
P3 Health employs about 400 people. The company is managed by 20 executives with a total tenure of roughly 934 years, averaging almost 46.0 years of service per executive, having 20.0 employees per reported executive. Recap of P3 Health's management performance can provide insight into the venture performance.
PIIIW |
P3 Health Management Team Effectiveness
The company has return on total asset (ROA) of (0.1202) % which means that it has lost $0.1202 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4125) %, meaning that it generated substantial loss on money invested by shareholders. P3 Health's management efficiency ratios could be used to measure how well P3 Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.31 in 2024. Return On Capital Employed is likely to drop to -0.31 in 2024. At this time, P3 Health's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 806.1 M in 2024, whereas Intangible Assets are likely to drop slightly above 601 M in 2024.Common Stock Shares Outstanding is likely to climb to about 309.3 M in 2024
P3 Health Workforce Comparison
P3 Health Partners is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 170,622. P3 Health adds roughly 400 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of (0.05) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.08) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.08. P3 Health Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific P3 Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on P3 Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, P3 Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Chicago Pacific Founders Ugp Iii, Llc over a month ago Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 90000 shares of P3 Health at 2.628 subject to Rule 16b-3 | ||
Chicago Pacific Founders Ugp Iii, Llc over three months ago Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 90000 shares of P3 Health at 3.009 subject to Rule 16b-3 | ||
Chicago Pacific Founders Ugp Iii, Llc over three months ago Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 90000 shares of P3 Health at 3.2417 subject to Rule 16b-3 | ||
Chicago Pacific Founders Ugp Iii, Llc over six months ago Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 90000 shares of P3 Health at 2.628 subject to Rule 16b-3 | ||
Bacchus Amir over six months ago Acquisition by Bacchus Amir of 3758130 shares of P3 Health at 375.81 subject to Rule 16b-3 | ||
Hudson Vegas Investment Spv, Llc over six months ago Disposition of 43974331 shares by Hudson Vegas Investment Spv, Llc of P3 Health subject to Rule 16b-3 |
P3 Health Notable Stakeholders
A P3 Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as P3 Health often face trade-offs trying to please all of them. P3 Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting P3 Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
MD MBA | Chief CoFounder | Profile | |
Aric MD | CEO President | Profile | |
Atul Kavthekar | CFO Officer | Profile | |
William Bettermann | Executive COO | Profile | |
Roy Youngblood | Director Compliance | Profile | |
Unmesh Srivastava | Chief Officer | Profile | |
BSN CRNI | Chief Staff | Profile | |
Leslie Fisher | General Affairs | Profile | |
Kassi APR | Culture Communications | Profile | |
Todd MHA | Chief Officer | Profile | |
Eric Atkins | Chief Officer | Profile | |
Scott Keim | Chief Officer | Profile | |
FACEP FACP | CEO Director | Profile | |
Jessica Puathasnanon | General Officer | Profile | |
Devery Goodey | Senior Technology | Profile | |
Karen Blomquist | Vice Relations | Profile | |
Lorie CPA | COO Chairwoman | Profile | |
David Yarger | Market Market | Profile | |
Leif Pedersen | Chief Officer | Profile | |
Thomas Conjurski | Exec Operations | Profile |
About P3 Health Management Performance
The success or failure of an entity such as P3 Health Partners often depends on how effective the management is. P3 Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of PIIIW management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the PIIIW management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.30) | (0.31) | |
Return On Capital Employed | (0.30) | (0.31) | |
Return On Assets | (0.07) | (0.07) | |
Return On Equity | (0.41) | (0.43) |
Please note, the imprecision that can be found in P3 Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of P3 Health Partners. Check P3 Health's Beneish M Score to see the likelihood of P3 Health's management manipulating its earnings.
P3 Health Workforce Analysis
Traditionally, organizations such as P3 Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare P3 Health within its industry.P3 Health Manpower Efficiency
Return on P3 Health Manpower
Revenue Per Employee | 3.2M | |
Revenue Per Executive | 63.3M | |
Net Loss Per Employee | 144.4K | |
Net Loss Per Executive | 2.9M |
Additional Tools for PIIIW Stock Analysis
When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.